Five weeks of resveratrol supplementation has no effect on GLP-1 secretion, gastric emptying, or glycemic control in type 2 diabetes (#375)

2:00 PM

Michelle J Bound

ADEA Poster Viewing One

Comparative effect of intraduodenal and intrajejunal glucose infusion on the gut-incretin axis response in healthy males (#70)

4:00 PM

Tongzhi Wu

ADS Clinical Orals: Gut and Glycaemia

Effects of vildagliptin and/or a whey preload on postprandial glycaemia in patients with type 2 diabetes using metformin (#259)

2:00 PM

Tongzhi Wu

ADS Clinical Poster Prize Presentations

Comparative effects of bile diversion and duodenal-jejunal bypass on glucose and lipid metabolism in diabetic rats  (#21)

10:15 AM

Xiang Zhang

ADS Basic Orals: Metabolic Regulation and Exercise

The glucagon-like peptide-1 (GLP-1) receptor agonist, exenatide, inhibits small intestinal motility, flow, transit and absorption of glucose in health and type 2 diabetes: a randomised controlled trial.  (#71)

4:15 PM

Chinmay S Marathe

ADS Clinical Orals: Gut and Glycaemia

Increased Capacity for Intestinal Serotonin Release in Obese and Diabetic Humans (#8)

9:00 AM

Richard L Young

ADS Clinical Orals: Obesity

Regional Variation in Expression of Enzymes that Synthesise Incretin Hormones and Glucagon in Lean and Morbidly Obese Humans (#265)

2:00 PM

Richard L Young

ADS Clinical Poster Viewing: Pot Pourri

A low-dose whey protein preload slows gastric emptying and improves post-prandial glycaemia in type 2 diabetes (#69)

3:45 PM

Linda E Mignone

ADS Clinical Orals: Gut and Glycaemia